Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab

Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab Acta Neurologica Belgica https://doi.org/10.1007/s13760-018-0948-2 LE T TER TO  THE   EDITOR Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab 1,2 3 Abdorreza Naser Moghadasi  · Seyed Mohammad Baghbanian Received: 20 March 2018 / Accepted: 22 May 2018 © Belgian Neurological Society 2018 Abbreviations Case presentation MS Multiple sclerosis TDL Tumefactive demyelinating lesions The patient was a 33-year-old woman on treatment with PML Progressive multifocal leukoencephalopathy glatiramer acetate and azathioprine who due to two attacks MOG Anti-Myelin oligodendrocyte glycoprotein within a year, her drug was changed to injection of natali- JCV John Cunningham virus zumab 300 mg per month. Four months after the injection HIV Human immunodeficiency virus of natalizumab, the patient experienced a blurred vision LP Lumbar puncture of the left eye. She did not have any clinical symptoms such as dementia, palsy and sensory disturbance. In brain MRI, two TDLs were observed (Fig. 1a, b). The cervical Introduction and optic nerve MRI was still normal without any gado- linium enhancement. The anti-aquaporin-4 antibody was re- Natalizumab has a positive impact on reducing attacks checked, which was negative. Anti-Myelin oligodendrocyte and can also reduce the incidence of new plaques in mag- glycoprotein (MOG) antibodies were also negative. John netic resonance imaging (MRI) of multiple sclerosis http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Neurologica Belgica Springer Journals

Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab

Loading next page...
 
/lp/springer_journal/tumefactive-demyelinating-lesions-in-a-patient-with-multiple-sclerosis-5gw9fW00o0
Publisher
Springer Journals
Copyright
Copyright © 2018 by Belgian Neurological Society
Subject
Biomedicine; Neurosciences; Neurology; Neuroradiology; Medicine/Public Health, general
ISSN
0300-9009
eISSN
2240-2993
D.O.I.
10.1007/s13760-018-0948-2
Publisher site
See Article on Publisher Site

Abstract

Acta Neurologica Belgica https://doi.org/10.1007/s13760-018-0948-2 LE T TER TO  THE   EDITOR Tumefactive demyelinating lesions in a patient with multiple sclerosis receiving natalizumab 1,2 3 Abdorreza Naser Moghadasi  · Seyed Mohammad Baghbanian Received: 20 March 2018 / Accepted: 22 May 2018 © Belgian Neurological Society 2018 Abbreviations Case presentation MS Multiple sclerosis TDL Tumefactive demyelinating lesions The patient was a 33-year-old woman on treatment with PML Progressive multifocal leukoencephalopathy glatiramer acetate and azathioprine who due to two attacks MOG Anti-Myelin oligodendrocyte glycoprotein within a year, her drug was changed to injection of natali- JCV John Cunningham virus zumab 300 mg per month. Four months after the injection HIV Human immunodeficiency virus of natalizumab, the patient experienced a blurred vision LP Lumbar puncture of the left eye. She did not have any clinical symptoms such as dementia, palsy and sensory disturbance. In brain MRI, two TDLs were observed (Fig. 1a, b). The cervical Introduction and optic nerve MRI was still normal without any gado- linium enhancement. The anti-aquaporin-4 antibody was re- Natalizumab has a positive impact on reducing attacks checked, which was negative. Anti-Myelin oligodendrocyte and can also reduce the incidence of new plaques in mag- glycoprotein (MOG) antibodies were also negative. John netic resonance imaging (MRI) of multiple sclerosis

Journal

Acta Neurologica BelgicaSpringer Journals

Published: Jun 6, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off